Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pressure Biosciences (PBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 5,966
  • Shares Outstanding, K 1,853
  • Annual Sales, $ 2,460 K
  • Annual Income, $ -9,700 K
  • 60-Month Beta 1.33
  • Price/Sales 2.64
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -12.76
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/21/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.5500 +27.06%
on 04/26/19
4.0300 -19.60%
on 04/15/19
+0.0400 (+1.25%)
since 03/26/19
3-Month
2.0100 +61.19%
on 01/28/19
4.0300 -19.60%
on 04/15/19
+1.0900 (+50.70%)
since 01/25/19
52-Week
1.5200 +113.16%
on 12/17/18
4.1000 -20.98%
on 10/02/18
-0.6600 (-16.92%)
since 04/26/18

Most Recent Stories

More News
Pressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2018 Financial Results and Provide Business Update

Conference Call Scheduled for Thursday, April 25th at 4:30pm ET

PBIO : 3.2400 (+0.62%)
Widespread Clinical Studies Can Reinvigorate the Legalization Movement for Cannabis

Researchers and scientists are constantly developing new, innovative medicines to effectively treat patients. However, the cost to conduct clinical trials and then receive approval to commercialize a drug...

SRNE : 3.66 (+0.83%)
NTEC : 5.97 (-2.13%)
NLBS : 0.2000 (unch)
ZYNE : 10.96 (+6.10%)
NEPT.TO : 5.35 (-0.74%)
PBIO : 3.2400 (+0.62%)
NEPT : 4.03 (+0.75%)
Some New Patients Choose CBD in Lieu of Opioids to Treat Persistent Ailments

Nearly 20% of U.S. adults suffer from chronic pain, while 8% are diagnosed with high-impact chronic pain, according to the National Institute of Health. Researchers from the Centers for Disease Control...

MDCL : 3.1000 (+0.32%)
MRMD : 3.2600 (-0.91%)
XXII : 1.92 (-0.52%)
NLBS : 0.2000 (unch)
TRST.TO : 10.11 (+0.90%)
PBIO : 3.2400 (+0.62%)
CTST : 7.52 (unch)
Uptick Newswire Hosts Dr. Bradford A. Young of Pressure BioSciences, Inc., on The Stock Day Podcast to Discuss the Commercialization of PBI's Proprietary UST and BaroFold Technology Platforms

PHOENIX, AZ / ACCESSWIRE / April 8, 2019 / Uptick Newswire recently welcomed Dr. Bradford A. Young, Senior Vice President and Chief Commercial Officer of Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI"...

PBIO : 3.2400 (+0.62%)
CBD and Cannabis Markets Continues to Grow Despite Regulations

Cannabis distributors and cultivators have been facing severe shortages due to the demand outpacing the supply in recent months. Specifically, the recent bout of legalization efforts has caused consumers...

NBEV : 5.41 (-6.88%)
TAP : 63.32 (+0.83%)
WTER : 2.29 (-0.87%)
CL.CN : 17.570 (+0.69%)
ORHOF : 9.4000 (+3.30%)
HEXO : 7.58 (+5.72%)
CRLBF : 13.1116 (+1.33%)
OH.CN : 12.600 (+2.77%)
NLBS : 0.2000 (unch)
PBIO : 3.2400 (+0.62%)
HEXO.TO : 10.20 (+5.59%)
Research and Regulatory Agencies add Credibility to the Rapidly Growing CBD Market

The cannabis marketplace has become one of the fastest growing global industries, as the rapid expansion of the cannabis market is largely due to the ongoing legalization efforts in many countries. The...

ACB : 9.02 (-0.55%)
ACB.TO : 12.09 (-1.06%)
ACBFF : 8.6900 (-12.80%)
GTII.CN : 20.530 (+0.54%)
VFF : 11.89 (+2.32%)
VFF.TO : 16.09 (+2.81%)
VLLFF : 2.4000 (unch)
NLBS : 0.2000 (unch)
PRAH : 97.51 (+1.18%)
ZYNE : 10.96 (+6.10%)
PBIO : 3.2400 (+0.62%)
GTBIF : 15.2500 (+0.33%)
Regions Continue to Shift Towards CBD Legalization With Growing List of Medical Applications

The proliferation of cannabidiol, or CBD-based products, has exploded after U.S. President Donald Trump signed the Farm Bill in December 2018. Now, CBD products are appearing at supermarkets, health and...

RKDA : 6.29 (-0.94%)
EMHTF : 2.9150 (+0.17%)
CWBHF : 19.3300 (+4.49%)
CWEB.CN : 26.000 (+4.25%)
EMH.VN : 3.910 (-1.01%)
NLBS : 0.2000 (unch)
NEPT.TO : 5.35 (-0.74%)
PBIO : 3.2400 (+0.62%)
NEPT : 4.03 (+0.75%)
CBD-Infused Beverages Achieve Quality and Clarity Breakthrough Utilizing Pressure BioSciences' Ultra Shear Technology Platform

New Video Demonstrates Revolution in Soft Drinks, Sports Drinks, and Beer with Vanishing Water-Soluble CBD Oil for Enhanced Quality and Absorption

PBIO : 3.2400 (+0.62%)
Pressure BioSciences Looks to Disrupt the Life Sciences Sector with Its Novel Technologies

Easton, Pennsylvania--(Newsfile Corp. - March 29, 2019) - recently published a full report on Pressure BioSciences, Inc. (OTCQB: PBIO), after the Company's latest surge in press coverage piqued the publication's...

PBIO : 3.2400 (+0.62%)
Biotechnology Companies Rush to Develop Treatments for Various Illnesses Found Globally

Diseases are commonplace around the world, especially in regions that don't have access to adequate healthcare. In such underdeveloped regions, diseases such as AIDS, malaria, and tuberculosis ravage countries...

CELG : 93.92 (-0.01%)
AZN : 37.92 (-2.92%)
PBIO : 3.2400 (+0.62%)
IMMU : 16.65 (-0.06%)
BMY : 45.44 (-0.44%)
NKTR : 31.79 (+0.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade PBIO with:

Key Turning Points

2nd Resistance Point 3.6040
1st Resistance Point 3.4120
Last Price 3.2400
1st Support Level 3.1140
2nd Support Level 3.0080

See More

52-Week High 4.1000
Last Price 3.2400
Fibonacci 61.8% 3.1144
Fibonacci 50% 2.8100
Fibonacci 38.2% 2.5056
52-Week Low 1.5200

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar